French drugmaker Sanofi has named its new company for major Active Pharmaceutical ingredients EuroAPI and announced Karl Rotthier as its future CEO with effect from Jan...
02.10.2018
- French drugmaker Sanofi has completed the divestment of its European generics business Zentiva to Advent International effective September 30. The transaction was finalized ahead...
02.09.2014
- An experimental cholesterol-lowering drug, alirocumab, from Sanofi and Regeneron Pharmaceuticals roughly cut in half the number of heart attacks and strokes in a clinical trial...
22.03.2012
- French drugmaker Sanofi said it plans to close a plant in northern England as it contends with European health spending cuts and growing competition from generic drugs. The Fawdon...
02.12.2010
- Sanofi-Aventis's CFO said a deal structure known as a contingent value right was interesting "in principle" but he declined to say if it was being discussed with bid target Genzyme...
